WMG Foundation supported this year’s race titled Race for the Cure, with the aim of raising awareness of breast cancer through the project Prevention as a Guarantee.
Race for the Cure, a race dedicated to prevention and support for women affected by breast cancer, was held on 28 September at Ada Ciganlija in cooperation with the organisation Europa Donna Serbia. This year, as in previous ones, the event gathered a large number of citizens, healthcare workers, companies, and various institutions from across Serbia.
The race represents the largest European sporting event dedicated to women’s health, whose goal is to help organisations and hospitals to raise funds for breast cancer treatment, as well as to increase public awareness of the disease in question.
About Breast Cancer
This is one of the most common malignant tumours in women. Doctors are not certain what the exact cause of this disease is, but they agree that certain factors can have a major influence — genetics, other types of cancer, early onset of menstruation, late childbirth, environment, lifestyle…
Prevention and early screening (mammography, ultrasound, breast self-examinations), together with the most advanced therapies, remain the best options for survival.
The goal is therefore to raise awareness of the importance of regular check-ups, to provide support to women facing the diagnosis, and to bring the entire community together in the fight for life.
Participants could choose whether they would take part in the 8 km race or the 3 km walk. In addition, this year saw many innovations, such as interactive content for different age groups, support zones, and messages of solidarity.
Funds collected from registration fees are intended for support programmes for women suffering from breast cancer and for organising free mammography screenings for women from vulnerable social groups.
According to official data, around 500,000 new cases of breast cancer are detected every year in Europe, while 125,000 women die from this disease. The statistics on disease incidence and mortality in Serbia are at a medium level compared to the rest of Europe, but we still lag behind the European average — for every 100 diagnosed cases, 8 more women die here than elsewhere in Europe.
In other words, out of every 5,000 newly diagnosed cases per year, 400 more women die in Serbia than the European average. For all these reasons, early diagnosis, screening, and treatment are extremely important and represent values also supported by the WMG Foundation.
